The relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients.

dc.authorid0000-0002-0077-6971
dc.authorid0000-0003-0128-6947
dc.authorid0000-0001-7934-7039
dc.authorid0000-0002-3793-5251
dc.contributor.authorBilici, Ahmet
dc.contributor.authorGöktaş Aydın, Sabin
dc.contributor.authorÇakır, Aslı
dc.contributor.authorÖlmez, Ömer Fatih
dc.contributor.authorErol, Vedat Buğra
dc.date.accessioned2024-03-13T08:22:21Z
dc.date.available2024-03-13T08:22:21Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Tıbbi Patoloji Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipAmerican Society of Clinical Oncologyen_US
dc.identifier.citationBilici, A., Göktaş Aydın, S., Çakır, A., Ölmez, Ö. F. ve Erol, V. B. (2023). The relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL, 02-06 June, 2023.
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue16
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12362
dc.identifier.volume41
dc.identifier.wos001053772000670en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorBilici, Ahmet
dc.institutionauthorGöktaş Aydın, Sabin
dc.institutionauthorÇakır, Aslı
dc.institutionauthorÖlmez, Ömer Fatih
dc.institutionauthorErol, Vedat Buğra
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBreast Cancer Patients
dc.subjectTumor-Infiltrating Lymphocyte (TIL)
dc.subjectChemotherapy
dc.titleThe relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients.
dc.typeConference Object

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: